Abstract

Saffron (Crocus sativus L.) and its main constituents, i.e., crocin and crocetin, are natural carotenoid compounds, which have been reported to possess a wide spectrum of properties and induce pleiotropic anti-inflammatory, anti-oxidative, and neuroprotective effects. An increasing number of experimental, animal, and human studies have investigated the effects and mechanistic pathways of these compounds in order to assess their potential therapeutic use in ocular diseases (e.g., in age related macular degeneration, glaucoma, and diabetic maculopathy). This narrative review presents the key findings of published clinical studies that examined the effects of saffron and/or its constituents in the context of ocular disease, as well as an overview of the proposed underlying mechanisms mediating these effects.

Highlights

  • In addition to uncorrected refractive error, age related macular degeneration (AMD), glaucoma, cataract, and other retinal diseases are the major causes of blindness worldwide [1,2,3,4]

  • While the lower crocin dose did not induce significant reductions compared to placebo, the study authors noted that this dose could clinically improve Central macular thickness (CMT), best corrected visual acuity (BCVA), HbA1c, and fasting glycaemia [39]

  • The exact mechanisms by which saffron and/or were its constituents of the 15 tested animals [42]. These findings suggest that crocins may be resynthesized from circulating crocetin, which can reach the retina following blood-brain barrier damage, as supported by the fact that no crocin or crocetin metabolites were found in healthy retinas or other parts of the central nervous system [42]

Read more

Summary

A Narrative Review of the Existing Evidence from

Aston University, School of Life and Health Sciences, Aston Triangle, Birmingham B4 7ET, UK;. Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham B4 7ET, UK;. WISDEM, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK. Translational & Experimental Medicine, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK

Introduction
Methods
Study Design
Action Time-Course of Oral Saffron Supplementation
Safety Profile of Oral Saffron Supplementation
Summary of the Literature
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.